Where I would invest $20,000 into ASX shares in February

a2 Milk Company Ltd (ASX:A2M) and these ASX shares could be great places to invest $20,000 in February…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I think buy and hold investing is a great way to grow your wealth. You only need to look at how $20,000 investments in these ASX shares have fared over the last 10 years to see how rewarding it can be.

With that in mind, if you have $20,000 to invest in the share market today, I would be investing it into these ASX shares:

a2 Milk Company Ltd (ASX: A2M)

I think this New Zealand-based fresh milk and infant formula company could be a great option for a $20,000 investment. It has been growing its earnings at a rapid rate over the last few years and I'm confident this strong form can continue. This is thanks largely to the increasing demand for its infant formula products in the massive China market.

Afterpay Ltd (ASX: APT)

Another option to consider investing the money into is this payments company. Due to the success of its global expansion and the growing popularity of buy now pay later with consumers and merchants, I think Afterpay can continue its meteoric sales growth over the coming years and deliver strong returns for investors.

Appen Ltd (ASX: APX)

Appen is a leading developer of high-quality, human annotated datasets for the machine learning and artificial intelligence markets. These markets are expected to grow exponentially over the next decade, which should lead to increasing demand for its services. Combined with recent acquisitions, I expect this to result in strong earnings growth from Appen for many years to come.

CSL Limited (ASX: CSL)

A final option for the funds could be this biotherapeutics giant. I think both its CSL Behring and Seqirus businesses are well-positioned for solid long term growth thanks to their popular products and burgeoning R&D pipelines. Another positive is the increasing demand for immunoglobulins and its growing plasma collection network. This should support strong earnings growth in the short term.

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of AFTERPAY T FPO and CSL Ltd. The Motley Fool Australia owns shares of A2 Milk and Appen Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.
Growth Shares

3 monster stocks to hold for the next 3 years

These 3 ASX shares operate in different industries and could be worth holding for long-term growth over the next 3…

Read more »

Person pointing at an increasing blue graph which represents a rising share price.
Growth Shares

2 ASX growth shares to snap up while they're still down

Brokers see plenty of upside for these mainstay sector picks.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

Why these ASX growth stocks could be much bigger in 2030 than today

These stocks have long growth runways and strong business models.

Read more »

A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
Growth Shares

3 incredible ASX growth shares to buy and hold forever in 2026

True long-term investing means owning businesses you’d be happy to hold through volatility, uncertainty, and decades of change.

Read more »

Happy work colleagues give each other a fist pump.
Growth Shares

2 shares to buy hand over fist before the ASX 200 soars higher in 2026

These shares are highly rated by brokers for a reason. Here's what you need to know about them.

Read more »

Buy now written on a red key with a shopping trolley on an Apple keyboard.
Broker Notes

Experts rate these 2 ASX shares as buys this month!

Leading analysts say these stocks are a buy.

Read more »

Happy healthcare workers in a labs
Technology Shares

Prediction: CSL shares could soar past $270 in 2026

Here's what to expect from the Australian-based global biotechnology company this year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Growth Shares

2 unstoppable ASX 200 stocks to buy in 2026 and hold forever

These blue chips could have very bright futures. Do you own them?

Read more »